1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Jaime Daniel Mondragon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dapagliflozin Effect in Cognitive Impairment in Stroke Trial Dapagliflozin 10mg Tab, Statins (Cardiovascular Agents), Platelet Antiaggregant - Stroke, Ischemic, Mild Cognitive Impairment | Phase 2 / Phase 3 | Unknown | Jaime Daniel Mondragon | 270 | 2020-08-01 | 2022-10-04 |
Cognitive Dysfunction (1) · Dementia, Vascular (1) · Ischemic Stroke (1) · Metabolic Syndrome (1)
Aspirin (1) · Atorvastatin (1) · Biguanides (1) · Bromocriptine (1) · Cardiovascular Agents (1) · Clopidogrel (1) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (1) · Hypoglycemic Agents (1) · Insulin Glargine (1) · Insulin Lispro (1) · Insulin, Isophane (1) · Platelet Aggregation Inhibitors (1) · Pravastatin (1) · Rosuvastatin Calcium (1) · Sulfonylurea Compounds (1)
Mexico (1)
PMID 20204386, PMID 23040716, PMID 28095900, PMID 28950419, PMID 29016744, PMID 29371333, PMID 29446769, PMID 29573529, PMID 31236801, PMID 31248555, PMID 31535829, PMID 32115470, PMID 32144994, PMID 32178931, PMID 32317958, PMID 32352644, PMID 32559474, PMID 32854852, PMID 33030307, PMID 33282811, PMID 33894597, PMID 34813630